GGrantIndex
Sort

39,280 grants matching leukemia

Pediatric Oncology Clinical Research Training Program

$756,000
Baylor College Of Medicine · K12 · FY2005 · CA

Biostatistics Core

$755,906
Peter A Jones · University Of Southern California · P30 · FY2015 · CA

Hematopoietic Stem Cell and Cord Blood Transplantation

$755,861
Effie W Petersdorf · Fred Hutchinson Cancer Research Center · U01 · FY2017 · AI

Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression

$755,852
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS

$755,670
Igor I Slukvin · University Of Wisconsin-Madison · R24 · FY2017 · OD

Immunotherapeutic targeting of gangliosides in Ewing Sarcoma

$755,393
Robbie G. Majzner · Dana-Farber Cancer Inst · U01 · FY2024 · CA

Center of Molecular Developmental Hematopoiesis

$755,211
Stuart H Orkin · Boston Children'S Hospital · P30 · FY2008 · DK

Discovering novel therapies for glioma patients

$755,171
Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Human Immune Responses to Tumor Antigens for Cancer Vaccine Development

$755,122
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Development of Recombinant Toxins to Treat Hematologic Malignancies

$754,944
Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Ikaros regulation: Study on hemolymphopoiesis

$754,702
Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2022 · HL

GEMS: Genomic approach to connecting Elevated germline Mutation rates with male infertility and Somatic health

$754,692
James Hotaling · University Of Utah · R01 · FY2024 · HD

Bioinformatic Tools in Cancer Research

$754,625
Kenneth Buetow · Division Of Basic Sciences - Nci · ZIH · FY2011 · CA

Development of therapeutic chemokine-based formulations

$754,563
Arya Biragyn · National Institute On Aging · ZIA · FY2014 · AG

Oncogenic Function of FBXW7 R465 mutation reveals a new opportunity for cancer therapy

$754,487
Suresh Kumar · National Institute On Aging · ZIA · FY2018 · AG

Vaccines and Therapeutics for Anthrax

$754,329
Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication

$754,264
Elizabeth Bouchard · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA

Structure and functional mechanisms of molecular chaperones and protein kinases

$753,785
Charalampos Kalodimos · St. Jude Children'S Research Hospital · R35 · FY2019 · GM

Structure and functional mechanisms of molecular chaperones and protein kinases

$753,785
Charalampos Kalodimos · St. Jude Children'S Research Hospital · R35 · FY2021 · GM

Structure and functional mechanisms of molecular chaperones and protein kinases

$753,785
Charalampos Kalodimos · St. Jude Children'S Research Hospital · R35 · FY2020 · GM

Structure and functional mechanisms of molecular chaperones and protein kinases

$753,785
Charalampos Kalodimos · St. Jude Children'S Research Hospital · R35 · FY2018 · GM

Project 2 - IMiD Resistance in Patients and Humanized Mice with Multiple Myeloma

$753,736
Peter Leif Bergsagel · Mayo Clinic Arizona · U54 · FY2017 · CA

Epigenetic regulation of cellular plasticity and cancer cell fate

$753,725
Yang Shi · Boston Children'S Hospital · R35 · FY2017 · CA

Digital PCR quantification of BCR-ABL for CML diagnosis and monitoring in a LMICs setting

$753,619
Daniel T Chiu · University Of Washington · UH3 · FY2020 · CA

Impact of PLCG2 Alzheimer's Disease Risk Variants on Microglia Biology and Disease Pathogenesis

$753,556
Bruce T Lamb · Indiana University Indianapolis · R01 · FY2024 · AG